United Health Products provided an update on the company’s FDA Premarket Approval application process. Due to further unanticipated delays in testing performed by external service providers, the company continues to await testing reports necessary for the preparation and filing of its revised PMA application. Testing of packaging activities completed to date have not indicated any adverse or unexpected results. There can be no assurance that the company’s PMA application will be approved.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on UEEC:
- United Health Products Reports on Product Testing for FDA Application
- United Health Products Reports on Progress in Product Testing
- United Health Products Reiterates Guidance on FDA PMA Application Process
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue